Roxanne Nelson
Nurse, Interrupted. Aka escapee from healthcare
Articles
-
1 week ago |
opmed.doximity.com | Roxanne Nelson |Piero Antuono
Brain–computer interfaces (BCIs)are a rapidly evolving field that merges neuroscience and technology. These systems establish direct communication pathways between the human brain and external devices, with the goal of restoring communication and mobility for people who have lost those functions. “As a community, when we meet someone with a cervical injury or stroke, we want to be able to say to them, you will be able to move again tomorrow,” said Leigh R.
-
1 week ago |
opmed.doximity.com | Roxanne Nelson |Piero Antuono
Obstructive sleep apnea (OSA) is associated with a higher incidence of developing Parkinson’s disease (PD), but it may be a modifiable risk factor, according to research presented at the American Academy of Neurology (AAN) annual meeting. Results of a large cohort study showed that individuals with OSA, who began CPAP within 2 years of their diagnosis, had a lower incidence of PD compared with those started later or not at all.
-
1 week ago |
opmed.doximity.com | Piero Antuono |Roxanne Nelson
The 77th annual American Academy of Neurology took place on April the 5th in San Diego. This is the leading neurology conference in the US and likely in the world with over 14.000participants (virtual and in person) for a total of 4257 scientific presentations. A change this year is the smaller number of foreign participants possibly due to virtual options and the uncertain economic and political climate. Things are changing.
-
1 week ago |
opmed.doximity.com | Roxanne Nelson |Piero Antuono
An investigational non-pharmaceutical device was able to effectively treat acute migraine attacks, according to research presented at the American Academy of Neurology (AAN) annual meeting. Significantly more patients using the Mi-Helper device, which delivers a controlled stream of conditioned air via a transnasal nebulized mist, had pain freedom at 2 hours vs. those who received sham.
-
Jul 23, 2024 |
biospace.com | Roxanne Nelson
Pictured: ADCs and money/Taylor Tieden for BioSpace For the first time, the global market size of antibody drug conjugates (ADCs) exceeded $10 billion last year, at an estimated $11.29 billion, according to Grand View Research. This trend is expected to continue for the next few years, with ADCs reaching an estimated worth of nearly $30 billion by 2028, according to the market intelligence firm Evaluate.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 243
- Tweets
- 3K
- DMs Open
- No
#New #York #state court rules against #Amish for #exemption from #school #mandated #vaccines. https://t.co/BG9NMMmXlM
The #CDC is planning a new #study to look at the possible link between #autism and #vaccines. Thus far no previous research has supported the link, but oh well. Is #RFK jr behind it? https://t.co/HibYfyMm4H
#Texas is experiencing its #worst #outbreak of #measles in 30 years. Most of the cases are #unvaccinated or status unknown. https://t.co/h4itnc0gKf